Aims: To identify the dominant subtextual themes and framing strategies used to establish obesity as a newsworthy subject. Methods: A search of the LexisNexis database and of current affairs television programs was undertaken between the months of May and September 2002. Articles relating to obesity and the food industry were analysed. Results: The material examined had similar format and framing strategies and used identical or previously used subtextual themes. The format commenced with a statement of the magnitude of the obesity problem supported by facts and statistics, discussed the causes of obesity, and attempted to blame persons or a body of people. Comments or "sound bites" were included, which employed the use of metaphors, and at the conclusion of the piece there was an attempt to offer a solution. To enhance newsworthiness, various framing strategies were employed; these include:
Dept. Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Japan Aims: To investigate whether the adipocyte-secreted hormone adiponectin (apM1), found to be decreased in obese subjects, can be considered as a component of the metabolic syndrome (MΣ), as defi ned by the NCEP-ATPIII criteria. Methods: Components of the MΣ, visceral adipose tissue (VAT; CT-scan L4-L5) and insulin resistance (IR; HOMA) were measured in 441 subjects (113 men and 328 women), with a mean age of 42±13 yrs and a mean BMI of 38.1±5.9 kg/m². Results: The presence of MΣ was diagnosed in 209 (47.4%) of the subjects. Subjects with the MΣ had lower levels of adiponectin (7.7±4.1 vs. 10.6±5.0 µg/ml) and higher levels of VAT (197±75 vs. 149±76 cm²) and IR (5.28±3.34 vs. 3.37±2.03) compared to subjects without the MΣ (p<0.001), even after correction for age (p<0.001). Signifi cant correlations were found between apM1 and the different components of the MΣ, except for blood pressure (waist: r =-0.33, HDLchol: r=0.53, TG: r=-0.34, fasting glucose: r=-0.14). In multiple regression analysis, HDLchol and waist were independent determinants of apM1, explaining 27% of the variability. Signifi cant negative relationships were found with VAT (r=-0.21) and IR (r=-0.41). Conclusions: ApM1 levels are decreased in subjects with the MΣ as defi ned by the ATPIII criteria and low apM1 values are related to most of the risk factors included in the MΣ.
T4:P4-004 PATTERN OF BODY FAT DISTRIBUTION IN OBESE AND NONOBESE ADOLESCENT GIRLS
Bazhan Marjan 1 , Gaffarpoor M. 2 , Houshiar-rad A.
Aims: To evaluate the BMD (L2-L4) patterns among overweight (OW) adolescents. Methods: A case-control study of 83 OW (BMI>P85) and 89 non-OW (P5<BMI<P85), frequency matched by age, gender, pubertal development and socio-economical status, selected from 1420 healthy, normal height (HAZ >-1) adolescents [15 to 19 years(Tanner IV and V)], attending a public high school of São Paulo city. Food intake/dietary habits was evaluated using the 4-day food record. DXA [LUNAR TM DPX-L] was used to evaluate BMD and the results categorized by having the sample median (1.2 g/cm 2 ) as a cut-off point. Seven covariates were included in the fi nal regression model. Inclusion criteria were p value of association with overweight < 0.10 in bivariate analyses and < 0.05 in the fi tted logistic regression models. Results: Prevalence of OW was 15.21%. Adjusted odds ratios for BMD > the median value for the studied population was 6.78, after controlling for matched variables in the design and for other potential confounders in the analysis as shown below.
Variables (yes=risk)
Adjusted OR (95% CI) 1)Parents obesity * 2.09 (1.05 -4.18) * 1, 2 and 3 adjusted
2)Obesity during pre-school period * 16. 28 (3.59 -73.16 
Conclusion:
The OW condition during adolescence is related to better BMD. We could argue if this bone characteristic, possibly beginning at more precocious ages, can represent a reduction in osteoporosis risk in adulthood when a correct diet and adequate physical activities will also contribute to lose weight.
T4:P4-009 THE INFLUENCE OF BODY MASS INDEX ON NUMBER OF VISITS TO GENERAL PRACTITIONERS IN THE UK Counterweight Project Team Royal United Hospital, Bath, UK
Aim: To examine the number of visits to General Practitioners (GPs) according to patients Body Mass Index (BMI).
Methods: A total of 6150 obese (BMI>=30) and 1150 normal-weight (BMI 18.5-<25) patients were randomly selected from 73 primary care practices in the UK. Medical records were retrospectively reviewed for the previous 18 months and GP appointments noted. Frequent attendance was defi ned as 4 or more visits.
Results: Obese patients visit their GP more frequently than their normal-weight counterparts (GP: 60.2% vs 46.8%; in 18 months p<0.001).
The mean numbers of GP appointments by BMI banding are: BMI 18.5-<25 = 5.0, BMI 30 -34.9 = 6.2, BMI 35-39.9 = 7.3, and BMI >40 = 8.3. After adjusting for age, sex and social deprivation, the odds ratio (OR) for frequent GP attendance (4 visits in 18 months) for obese patients was 1.62 (95%CI 1.37-1.92). Testing for trend across the obese BMI bands showed a signifi cant relationship (p<0.001). After further adjusting for the number of known obesity-related co-morbidities, this relationship was weakened but not fully explained (OR 1.31; 95% CI 1.10-1.56). No signifi cant trends across BMI categories in the obese (BMI > 30) were then found (p=0.235).
Conclusions: Obese patients attend their GP signifi cantly more often than normal-weight patients. Within the obese, the higher attendance rates with increased BMI are largely attributable to the number of obesity-related co-morbidities.
T4:P4-010 THE IMPACT OF OBESITY ON POLYPHARMACY Counterweight Project Team Glasgow Royal Infi rmary, UK
Aims: To determine the impact of obesity on polypharmacy in the primary care setting.
Methods:
The Counterweight Programme is a national multi-centre initiative aimed at auditing and improving obesity management in primary care. 1150 obese patients (Body Mass Index, BMI>30 kg/ m 2 ) and 1150 age-and sex-matched normal-weight controls (BMI 18.5<25 kg/m 2 ) were randomly selected from primary care registers and data were collected on all prescriptions issued over an 18-month period. Individual drugs were "mapped" onto their root drug, e.g. Ceporex and Kefl ex were both "mapped" onto the root drug cefalexin. To assess the impact of obesity on "polypharmacy", numbers of patients receiving at least 4 different root drugs over the 18-month period were calculated. Results: 615 (53.5%) obese patients received at least 4 root drugs over the 18-month period compared with 436 (37.9%) in the normalweight group. Age, sex, deprivation category of prescribing practice, presence of co-morbidity and increasing degree of obesity all had a signifi cant infl uence on results. In addition, a statistically signifi cant increase on the level of polypharmacy was noted, with increasing degree of obesity even after adjustment for age, sex, deprivation score and presence of co-morbidity. Conclusions: Obesity has an additional impact on prescribing over and above the prescribing consequences related to clinical conditions associated with obesity. Aims: To determine bone mass using the DXA technique in women with morbid obesity selected for the restrictive bariatric procedure of the stomach. Methods: Bone mineral desity (BMD) at the lumbar spine, proximal femur and total skeleton as well as fat mass (FM) and lean body mass (LM) were measured by dual-energy X-ray absorptiometry (DXA) in 24 morbidly obese women. The mean age of the patients was 37 y (range 24-57) and the mean body mass index (BMI) was 47.5 kg/m 2 (range 36.8-53.3). The control group consisted of 24 age-matched non-obese women. In both groups, renal, hepatic and metabolic bone diseases were excluded as well as drug therapy, which might infl uence bone metabolism. Results: BMD and BMC in both groups did not differ. In the obese patients, there was a negative correlation of BMD of lumbar spine to BMI (r -0.470, P<0.05). There were no signifi cant correlations between BMD and both FM and LM. Conclusions: Morbid obesity is not a protective factor when one considers the risks for osteoporosis.
T4:P4-011 BONE MASS IN WOMEN WITH MORBID OBESITY

T4:P4-012 INFLUENCE OF OBESITY ON PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Damjanovic Miodrag Health Center, Leskovac, Serbia, Yugoslavia
Aims: The aim of this paper is to show the effects of obesity on prognosis of patients with acute myocardial infarction (AMI). Methods: We examined 591 patients with AMI managed in the coronary care unit of the Health Center Leskovac, and followed up 34 months averagely. Obesity was defi ned as body mass index 27.8 and ≥ 27.3 in men and women, respectively. We studied te appearance of next coronary events: in-hospital deaths, residual angina pectoris, reinfarction, coronary angiography, myocardial revascularization and deaths after discharge (in 90, 68, 68, 6, 65 and 41 patients, respectively) . The control group (253 patients) consisted of the patients without these coronary events. The patients were classifi ed only once by presence of one more severe event. All comparisons were done related to the control group. Results: Obesity in patients with in-hospital deaths, residual angina, reinfarction, coronarography, myocardial revascularization and fatal outcome after discharge was registered in 25 (27.8%), 24 (35.3%), 22 (32.4%), 1 (16.7%), 21 (32.3%) and 16 patients (39.0%), respectively, and in 71 patients (28.1%) in control group. There is no statistical signifi cance between the examined subgroups versus control group. Conclusions: Our results showed that there are more patients with AMI and obesity in subgroups with residual angina, reinfarction, myocardial revascularization and dead after discharge than in the control group, but there is no signifi cant difference between subgroups and the control group. Aim: Data from Vienna showed that 12 -22 % of children between the age of 10 and 15 years are overweight, 5 -10 % are obese and up to 2 % morbid obese. With PRESTO a school-oriented pilot project has been launched due to the obvious necessity of preventing overweight and obesity in children and adolescents. Methods: PRESTO was carried out in six fi rst-grade grammar and six fi rstgrade comprehensive school classes in Austria, mainly Vienna. The same number of classes served as a control group. The school-oriented intervention was performed by a multi-professional team (physician, psychologist, nutritionist, expert for physical activity). In the beginning, medical examinations were performed in cooperation with school physicians and the knowledge about nutrition as well as eating habits have been raised. Eleven nutrition-related sessions, one hour per week in each class, were followed by a check on short-term and on long-term basis. Additionally, teachers should include themes of nutrition and health in their subjects suitably to the curriculum. Physical education teachers were informed about appropriate exercises and sessions on a common day of physical activity. Results: First evaluations show that knowledge about nutrition and eating habits have to be improved. Participation in the project has greatly motivated pupils for nutrition and health themes. Conclusion: PRESTO is designed to answer the questions: Can school intervention infl uence the fi elds of nutrition, physical activity and health? How largely is the increase of knowledge? Is this of short-term and longterm duration? Does knowledge mean conversion? After complete and successful evaluation, PRESTO should be expanded onto other schools throughout Austria. Result: The result showed that the mean age, weight, height and BMI were: 15 ± 0.5 (years), 56.4 ± 10.2 (kg), 158.8 ± 5.4 (cm) and 22.83 ± 6.2 (kg/m²), respectively. By NHANESI standard, the percentage of underweight, normal and overweight girls were 5.2%, 47.4% and 3.4%, respectively. 44% of the students had other stages of malnutrition problems.
T4:P4-013
T4:P4-014 ANTHROPOMETRIC STATUS OF ADOLESCENT GIRLS IS
Conclusion:
The result showed that the anthropometric status of young adolescent girls was not desirable and may cause nutritional problems in a generation who are supposed to be the future mothers. Therefore, increasing nutritional knowledge by using attractive modern technology for both parents and adolescents from mass media, especially TV programs, is highly recommended. [97.0 ± 16.8,M vs 105 ±16.4,F %, p<0 .05] that were reduced in males. Prevalence of subnormal (<90%) VC% was twice higher in the male than in female group (41 vs 20 %). Conclusions: These preliminary data confi rm in both sex the initial impairment of respiratory function in young adults uncomplicated severely obese. The 6-min walking test -a light respiratory stress-is able to unmask the impairment of the spirometric indexes in a preclinical stage. As expected, severely obese males have increased lean body mass and energy expenditure compared to females.
T4:P4-
Supported by Interuniversities Center for Study of Obesity (CISRO).
T4:P4-016 ABDOMINAL FAT INDEX (AFI) DOES NOT ESTIMATE THE METABOLIC RISK FACTORS OF CARDIOVASCULAR DISEASE BETTER THAN WAIST CIRCUMFERENCE IN SEVERE OBESITY
Guzzaloni Gabriele, Minocci Alessandro, Marzullo Paolo, Liuzzi Antonio Unit of Internal Med., Scientifi c Inst. S. Giuseppe, Auxological Italian Institute, Verbania, Italy Aims: To evaluate by ultrasound the role of the ratio between the thickness of preperitoneal (P) and subcutaneous (S) fat (AFI), in quantifying the cardiovascular risk in 258 obese patients (BMI 41.2 ± 6.3 [kg/m 2 ]; age 45.1 ± 13.6 years). Methods: Fasting plasma glucose, insulin, lipidemic profi le, uric acid and fi brinogen were measured. Moreover, Fat-Free Mass (FFM) and Fat Mass (FM) by bioelectrical impedance, insulin resistance expressed by homeostasis model assessment (HOMA), body fat distribution by waist girth and abdominal fat distribution by AFI were calculated. Patients were divided into quartiles of BMI. Results: AFI lowered at increasing BMI and showed a weak positive correlation with TGL and uric acid and a negative correlation with HDL in the lower quartiles of BMI. When BMI exceeded the value of 45.2, these correlations were lost. S correlated positively with uric acid, and negatively with HOMA and TGL; P correlated positively with CHOL and TGL, and negatively with HDL. Waist girth showed more signifi cant correlations than AFI, with the indices of cardiovascular risk in the lower quartiles of BMI but not at the highest BMI quartile. Conclusions: AFI, P and S do not seem useful in quantifying the metabolic risk factors of cardiovascular disease in obese subjects, and this measurement does not seem to be more advantageous than waist girth.
T4:P4-017 PERCEIVED WORKING ABILITY AND SICKNESS ALLOWANCES IN OBESE SUBJECTS BEFORE AND AFTER A REHABILITATION COURSE
Hakala Paula, Karppi Sirkka-Liisa, Marniemi Jukka, Rastas Merja, Virta Lauri Social Insurance Institution,Turku, Finland Aims: To evaluate the effects of a rehabilitation course on perceived working ability and sickness allowances in obese subjects with musculoskeletal diseases. Methods: The rehabilitation course consisted of three in-patient periods within 6 months, led by a multiprofessional team at a rehabilitation centre. Working ability was assessed by means of a questionnaire at the baseline and 6, 12 and 24 months later. Data on sickness allowances were obtained from the records of the Social Insurance Institution. The study population consisted of 39 women and 10 men; age 30-60 years, mean BMI 39 kg/m 2 .
Results:
The mean weight loss at 24 months was 4.4% (p<0.01) for women and 5.6% (p< 0.05) for men. In women, the working ability index increased from 28.9 to 31.2 during the course (p<0.01), but decreased to the baseline level by 24 months. In women, 11% at baseline, 31% at 12 months and 21% at 24 months perceived their working ability as 'good' or 'excellent'. For men, virtually no changes were observed in the working ability. Of all subjects, 43% had received sickness allowances in the year preceding the course. The percentage fell to 33% during the second follow-up year, because two women were entitled to disability pension and three women to unemployment benefi ts.
Conclusions:
The rehabilitation course had a favourable short-term effect on perceived working ability in women, but not in men. New approaches are needed to promote and sustain long-term work ability and to reduce the need of sick leaves among obese people. Aims: To evaluate the prevalence of the metabolic syndrome(MS) and associated factors among Korean obese patients who seek obesity clinic. Methods: The study was conducted at 26 obesity clinics during 6 months in [2001] [2002] . The study subjects were those with body mass index (BMI) ≥ 25kg/m 2 , aged above ≥20 years, for whom anthropometric variables, blood pressure, and blood tests had been measured. The data on lifestyle-related factors were collected by self-reported questionnaires. Multiple logistic regression analysis was used for men and women, respectively, to estimate the odds ratios (OR) of the MS by independent variables. Results: The overall prevalence of the MS in obese subjects was 61.0% in men and 43.7% in women. In women, older age group (≥51 year-old) had a higher prevalence of the MS. The OR of the MS in the severe obesity group (BMI ≥30) were 2.4 for men and 1.8 for women. Obese men who were frequent alchohol drinkers (≥3/wk) showed a signifi cantly higher risk (OR, 4.6) than that of the lesser frequent alcohol drinkers (0-2/wk). Women who exercised more than six times per week showed lower risk (OR, 0.26) 
T4
Aims:
To determine the level of knowledge of Greeks about obesity and their experience in weight-loss methods. Methods: A telephone survey was conducted on 500 self-reported overweight subjects, both sexes, from urban and rural areas of Greece. The questionnaire was designed to refl ect their experience of weightloss programs and their general knowledge on obesity. Results: In all, 91% of the sample considered obesity as a serious health problem and 62% as a disease; 41% had tried to lose weight by following a "healthy diet", 33% a particular weight-reducing diet, 32% had chosen exercise and 23% had never attempted weight loss. A total of 43% of women had chosen dietary treatments, comparing to only 23% of men, whereas men had shown preference to exercise (39%), more than women (25%), as a means of weight loss. In addition, exercise was chosen more frequently among subjects of a higher socioeconomic background. From the subjects that had attempted to lose weight, 75% had gone on a reducing diet at least once a year and in 59% the diet lasted up to a month. The main source of the diet was a dietician (24%) and only 12% referred to specialist doctors.
Conclusions:
The general public knowledge is that obesity is a health problem and that a healthy lifestyle including exercise and healthy eating is the best way to manage it. However, only a small percentage uses reliable sources for weight loss. Aims: The aim of this study was to elucidate the relationship between nonalcoholic fatty liver disease diagnosed by ultrasonography and the metabolic syndrome defi ned by NCEP-ATP III criteria. Methods: Sixty-nine adult male subjects with negligible alcohol consumption underwent an anthropometric and laboratory investigation. The ultrasound scan of the liver was performed to determine the presence and the severity of nonalcoholic fatty liver disease. Results: Nonalcoholic fatty liver disease was diagnosed in 36 cases by ultrasound scan. According to the severity of nonalcoholic fatty liver, triglyceride, HDL-cholesterol, alanine aminotransferase, aspartate aminotransferase, fasting insulin level, HOMA-IR, and obesity-related variables (body mass index, percent body fat, waist circumference) showed the signifi cant linear trend. The independent variables that accounted for the severity of nonalcoholic fatty liver disease were triglyceride, waist circumference, and alanine aminotransferase, which is the predictor of nonalcoholic steatohepatitis. The prevalence of metabolic syndrome was 41% vs 6.1% in the nonalcoholic fatty liver group vs control group, respectively, and the odds ratio was 11.1 (95% CI 2.29-53.6). The prevalence of nonalcoholic fatty liver was increased with increase in the number of features of metabolic syndrome. Conclusion: Nonalcoholic fatty liver disease is closely related to the metabolic syndrome and the severe classifi cation of nonalcoholic fatty liver by ultrasound scan could be useful to predict the severity of insulin resistance, and the risk of nonalcoholic steatohepatitis. Aims: Rise in plasma-free fatty acid (FFA) level has been reported to be associated with insulin resistance. We evaluated cross-sectionally the relationship of FFA concentration to body composition, the level of hepatic steatosis, and glucose metabolism in obese subjects. Methods: In 305 outpatients in our clinic (179M/126F, 33+/-12 years, BMI: 32.2+/-5.5), (1) glucose, insulin and FFA during 180 minutes of 75g oral glucose load, (2) abdominal subcutaneous and visceral fat areas (SFA, VFA) (n=291), (3) liver to spleen ratio of CT numbers (L/S ratio, an index of hepatic steatosis), and (4) % body fat by underwater weighing (n=254), were measured. Results: (1) Although no difference was found in BMI between men and women, men showed higher FFA area during glucose load and lower L/S ratio. (2) In both men and women, FFA area correlated positively with BMI, %BF, VFA, SFA, and negatively with L/S ratio. (3) FFA area and fasting FFA correlated positively with glucose area in both men (r=0.31 and 0.26, respectively) and women (0.42, 0.30). These two parameters showed positive correlation with {glucose area/180 -fasting glucose value}, an index of postprandial glucose elevation, but no or weaker correlation with fasting glucose level. FFA area and fasting FFA showed no correlation with insulin area or HOMA-IR in men, and in women after adjusted for BMI. Conclusions: These data show that plasma FFA level is closely related to body fat accumulation, hepatic steatosis, and postprandial glucose intolerance in obese subjects. Aims: To determine if there is an infl uence of BMI on the radiological progression in early and longer duration rheumatoid arthritis (RA). Methods: In all, 54 RA patients (27 with early RA) were observed in a progressive 2-year follow-up for radiological progression of joint damage. Monitoring of: BMI at the beginning and end of the study, HLA-DRB1 alleles, initial joint erosions, duration of disease, age, sex, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). The outcome was defi ned as radiographic damage according to yearly increase of Larsen score (LS). Results: Increased joint damage was signifi cantly correlated with lower BMI (r = 0.363, p < 0.05), the presence of initial joint erosions (r = 0.341, p < 0.01), ESR (r = 0.315, p < 0.05), and CRP (r = 0.427, p < 0.01) at study entry. Patients with an increase of LS 5.8/yr had a lower weight at the beginning of their complaints (BMI 24.8 ± 4.7 vs 27.8 ± 3.8; p < 0.05) as well as after the time of observation (BMI 24.6 ± 3.7 vs 27.6 ± 4.9; p < 0.05). A logistic regression revealed a BMI < 27 at the beginning of disease (ß=2.04, p=0.003, OR 7.69), the presence of HLA-DR4 shared epitope (SE) (ß=1.76, p=0.015, OR 5.82), and joint erosions at study entry (ß=1.56, p=0.044, OR 4.78) as predictors for joint damage. Conclusions: Together with the HLA-DR4 SE and erosions at study entry, a low BMI at the beginning of RA was associated with higher radiographic progression. Obesity could prevent an erosive course of RA. Aims: To investigate the relationship between synovial tissue (ST), collagen degradation and body mass index (BMI) in patients with rheumatoid arthritis (RA) and osteoarthritis (OA); to offer further support that the BMI infl uences the extent of the radiological ascertainable joint damage (further abstract). Methods: Collection of ST (knee replacement surgery), serum and urine (simultaneously) from 28 RA and 21 OA patients. BMI, erythrocyte sedimentation rate (ESR) and C-reactive protein (CrP) were recorded. Using the median BMI of 27, RA patients were grouped into those with relatively low (<27) or high (≥27) BMI. After hydrolysis, ST and urine were quantifi ed for their pyridonoline (Pyr) and deoxypyridinoline (Dpyr) content using a gradient ion-paired reversed-phase HPLC method. 
T4
T4:P4-
T4:P4-024 BENEFICIAL ROLE OF OBESITY IN PREVENTING SEVERE RHEUMATOID JOINT EROSIONS -EXPERIMENTAL RESULTS SUPPORT CLINICAL DATA
Conclusions:
The collagen degradation of joint tissues was found to be decreased in overweighted RA and OA patients. The results are in agreement with data on radiological progression, which also have proven to be infl uenced by BMI. Obesity could offer protection from severe joint damage. and 19 age-and BMI-matched cycling women underwent carotid scanning for estimating the Intima-media thickness (IMT). Several risk factors for atherosclerosis were also assessed. Results: The IMT was signifi cantly higher in PCOS group than the control group (p<0.05) and was correlated with BMI, HDL-cholesterol, systolic and diastolic blood pressure, serum insulin and HOMA-IR, PAI-1, and total testosterone level (p<0.05 in each). Factors affecting IMT were serum insulin and HOMA-IR, total testosterone level, and PCOS status. Conclusions: PCOS women seem to have an increased risk of premature atherosclerosis even though they are lean and young. Supraphysiologically elevated testosterone level may accelerate early atheroma formation in nonobese young PCOS women.
T4:P4-025 ELEVATED TESTOSTERONE LEVEL CONTRIBUTES TO PREMATURE ATHEROSCLEROSIS IN NONOBESE YOUNG WOMEN WITH POLYCYSTIC OVARY SYNDROME
T4:P4-026 CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) AS BIOMARKER OF OBESITY IN ALCOHOL DRINKERS
Kim Sung-Soo, Kim Jong-Sung Dept. of Family Medicine, College of Medicine, Chungnam National University, Daejeon, South Korea Aims: Obesity might be expected to correlate with alcohol consumption. However, there are many epidemiological studies that suggest absent or weak associations between alcohol and obesity. The assessment of the effects of alcohol on obesity may be in need of biomarkers in addition to the amount of alcohol. The aim of this study was to investigate the association between biomarker of alcohol consumption and obesity. Methods: This study involved 24 males with moderate drinking (< 14 drinks/week) and 16 males with heavy drinking (≥ 14 drinks/ week). Both groups had meals regularly. The association between anthropometric markers and alcohol consumption (amount and biomarkers) was analyzed in both groups. Biomarkers included carbohydrate-defi cient transferrin (CDT), gamma-glutamyltransferase (GGT) and erythrocyte mean corpuscular volume (MCV).
Results: There were no differences of body mass index (BMI), waist circumference (WC), weight and age in both groups. The amount of drinking (drinks/week), CDT and GGT in heavy drinkers were higher than in moderate drinkers (p < 0.05). After controlled for age, CDT was associated with WC (r = 0.7518, p = 0.019) and BMI (r = 0.6945, p = 0.038) in heavy drinkers, but not in moderate drinkers. GGT, MCV and the amount of drinking were not associated with BMI in both groups. Conclusions: These results suggest that CDT may be benefi cial in predicting the development of obesity in heavy drinkers with meals regularly. International Obesity TaskForce, London, UK Aims: To assess the change in obesity in Eastern Europe since 1989, in comparison with Western Europe, and to highlight the economic implications of this change. Methods: Available data are reviewed and data comparability is discussed critically. The potential economic costs of the observed patterns of obesity in Eastern Europe are explored, drawing upon relevant studies largely applied to Western Europe. Results: Obesity is no longer a phenomenon confi ned to wealthier parts of the world such as Western Europe. Unfortunately, it is also increasingly found in countries in economic transition in Eastern Europe. As in Western Europe, there is considerable variation in trends and prevalence of obesity within Eastern Europe. Part of this variation appears to be related to the level and pace of economic development. The observed trends already impose a substantial economic burden on the countries concerned, both in terms of direct health care and indirect productivity costs. Conclusions: Policymakers in Eastern Europe can learn from the Western European experience and act now to stem the obesity epidemic from further developing and, in so doing, reduce the substantial economic losses associated with obesity. More research is needed to explore the causes of the rise in obesity and to devise optimal, contextually relevant strategies to combat the problem, given the existing politico-economic constraints. Aims: The aims of the present study were: (a) to evaluate whether BMI or BF% does better refl ect hyperglycemia and pathologic lipid profi le in middle-aged women, and (b) to reveal the thresholds of these indices, as regards abnormal values of the above parameters. Methods: Twenty-fi ve pre-and 56 post-menopausal women (age: 53±6 y) participated in the study. BF% was estimated using the bioelectrical impedance analysis method. Serum insulin, glucose and lipids levels were measured. Insulin resistance (IR) was estimated using the homeostasis model. The cut-off points for BMI and BF % were calculated by ROC curve analysis. Results: Forty seven % of the women were overweight (BF%: 41.43±2.24) and 37% were obese (BF%: 47.37±3.47). Values of BMI and BF%, which had an optimal diagnostic ability for glucose> 110 mg/dl, were 29.7 (sens: 80%, spec: 68%) and 43.9 (sens: 70%, spec: 68%), respectively; for cholesterol> 200 mg/dl, 28.7 (sens: 52%, spec: 62%) and 44.7 (sens: 39%, spec: 81%); for LDL> 100 mg/dl, 28.7 (sens: 49%, spec: 83%) and 41.9 (sens: 52%, spec: 83%); for HDL< 60 mg/ dl, 28.7 (sens: 59%, spec: 65%) and 42.3 (sens: 56%, spec: 69%). Based on several regression models, BMI and BF% had similar explanatory ability, as regards glucose, insulin, cholesterol, LDL, HDL and triglyceride levels and IR, although high BF% even in women with normal BMI was observed (the statistical power in all analyses was > 80%). Conclusions: No difference in explanatory ability between BMI and BF% was observed, as regards glucose and lipids abnormalities, while only values of BMI ≥ 29 seem to be sensitive indices for hyperglycemia but not for hyperlipidemia, in middle-aged women. Aim: To analyse the prevalence of metabolic syndrome (MS) among Type-2 diabetic patients, and also the infl uence of obesity on glycemic control and vascular complications of diabetes mellitus. Methods: We analysed the data of 100 out-patient Type-2 diabetics (age: 43-78 yrs.). MS was defi ned according to the ATP III criteria, glycemic control was assessed with HbA1c. We also analysed the occurence of vascular complications (neuropathy, retinopathy, nephropathy, macroangiopathy). Results: In all, 37 diabetics were obese (BMI>30). MS was found in 50 diabetics (50%), obesity was its second main feature (in 66%) after hypertension (in 86%). Diabetics with MS had more than one vascular complication in 36%, diabetics without MS only in 24%. We found no infl uence of obesity on the occurrence of any vascular complication in our Type-2 diabetics. Altogether, 20% diabetics without obesity and only 5% obese diabetics were under good glycemic control (HbA1c<6.5%). We have found bad glycemic control (HbA1c>8.0%) in 36% non-obese diabetics, and in 45.9% obese patients. Conclusions: 1. Obesity is a frequent feature of MS in Type-2 diabetics, without infl uence on the incidence of vascular complications in our diabetics. 2. MS seems to be more responsible for vascular complications of diabetes mellitus as obesity alone. 3. Obesity deteriorates metabolic control in Type-2 diabetics. Aims: To examine if diabetics with increased BMI has increased coagulability compared with diabetics of normal BMI. Methods: Seventy, type 2 diabetic patients, were divided into 2 groups according to their BMI (<or>30). In these patients, we measured protein C and S, ATIII, activated protein C resistance in the absence of factor V Leyden, homocysteine levels and antiphospholipid antibodies. Results: Statistical signifi cance (SS) was remarked in fi brinogen levels of obese compared with non-obese diabetics (3.93 vs 4.33, p=0.041), whereas there was no SS in ATIII (89.4 vs 89.2), protein C (117 vs 99), protein S (89 vs 82.6), APCR (1.0037 vs 0.98), L1/L2 (1.20 vs 1.21), PT (11.1 vs 11.2) and PTT (32.2 vs 32.65). Conclusions: There was no SS in several coagulation tests between diabetic patients with increased and normal BMI. Larger studies will establish the pathogenetic relationship between diabetes and hypercoagulable status.
T4:P4-027 OBESITY IN EASTERN EUROPE: A CONSIDERABLE HEALTH AND ECONOMIC BURDEN?
T4:P4-028 BODY MASS INDEX (BMI) AND BODY FAT (BF) % AS INDICES
T4:P4-029 OBESITY LEADS TO DIFFICULTIES IN THE MANAGEMENT OF TYPE-2 DIABETES MELLITUS
T4:P4-
T4:P4-032 THE PATTERN OF OBESITY-RELATED DISEASE AND THE RELATIONSHIP BETWEEN OBESITY-RELATED DISEASE AND ITS VARIABLES ON OBESE PATIENT LEE SEON YEONG Sanggye Paik Hospital, Inje University, Seoul, South Korea
Aims: The obese people have increased recently and obesity is an important risk factor for many serious medical complications, which has led to public health problem in Korea. The objective of the present study is to determine the pattern of obesity-related disease and the relationship between obesityrelated disease and its variables. Methods: The total number of 458 cases (male 95, female 363) were gathered from January 2000 to December 2001 at the obesity clinic and body mass index, fat percent, waist circumference, blood pressure, fasting glucose, total cholesterol, HDL-cholesterol, triglyceride, uric acid measured. Results: The subjects were aged 5-72y. The number of children and adolescents (aged 5-18) was 117 (25.5%). Body mass index and waist circumference showed signifi cantly positive correlation with age in both men and women. The prevalence of hypertension was 17.5%, impaired glucose tolerance 6.1%, diabetes mellitus 2.4%, hyperlipidemia 27.5%, abnormal liver function test 22.7% and hyperuricemia 5.2%, respectively. Among children and adolescents, the prevalence of hypertension was 3.4%, hyperlipidemia 17.1%, abnormal liver function test 25.5%, and hyperuricemia 7.7%. The prevalence of hypertension, abnormal liver function test and hyperuricemia increased along with age and increased in men. The prevalence of hypertension, hyperlipidemia, and diabetes mellitus increased with age. The prevalence of obesity-related disease increased as obesity indexes (body mass index, fat percent, waist circumference) increased in both men and women. Conclusions: The prevalence of obesity-related disease increased as obesity indexes increased. Obesity is an important public health problem. So, it needs to manage obesity through public health policy about risk population.
T4:P4-033 NONALCOHOLIC FATTY LIVER DISEASE (NFLD) IN OVERWEIGHT (OW) BRAZILIAN ADOLESCENTS
Aims: To assess NFLD as a concomitant factor of OW among Brazilian adolescents. Methods: A case-control study of 83 OW (BMI>P85) and 89 non-OW (P5<BMI<P85). Cases and controls were frequency matched by age, gender, pubertal development and socio-economical status, selected from 1420 students (15 to 19 yr) attending a public high school of São Paulo City/Brazil. Indicators of NFLD were ultrasographic (US) study, ALT and gamma-GT. Eight covariates were included in regression models. Inclusion criteria were p value of association with OW < 0.10 in bivariate analyses and < 0.05 in the fi tted logistic regression models. Results: Prevalence of OW was 15.2%. Percentages of US fatty liver were 27.7 in OW and 3.4 in non-OW students. After controlling for matched variables in the study design and for other potential confounders in the analysis, as shown below, the adjusted OR for US fatty liver was 9.96. Variables (yes=risk) Adjusted OR (95% CI) * 1) 2) and 3) 1)Parents' obesity * 2. Results: A comparison of four indices proved that all of them are characterized by a similar relation with the studied diseases. The cutoff points with both maximal sensitivity and specifi city detection for IGT and DM2 were different for different sex, and for DM2 were: WC -97 cm, WHR -0,91, WHtR -0,62, BMI -29,2 kg/m 2 for women and 99 cm, 0,97, 0,57, 27,9 kg/m 2 for men, respectively. Conclusions: All the studied indices have a similar value for DM2 risk assesment. WC is especially noteworthy for everyday doctor's practice. The cut-off points of the studied indices should be differentiated according to sex.
T4:P4-035 INFLUENCE OF PARENTAL MEAL PRACTICE UPON ELEMENTARY SCHOOL CHILDREN HABITS OF TWO DIFFERENT ECONOMIC STATUSES. PRELIMINARY RESULTS
López-Alvarenga Juan Carlos, Castaneda-López Norma Jacqueline, Robles-Contreras Lorena , Vásquez-Velázquez Verónica , González-Jauregui Claudia, Manjarrez-Martínez Iliana, González-Barranco Jorge Instituto Nacional de la Nutricion Salvador Z, Mexico City, Mexico Obesity in adulthood is related to obesity in childhood, probably associated to familial meal habits. We analysed parental food preferences and their effect on children according to gender and economical status. Children and their families from a state elementary school (SS, n=300) and a private middle class school (PS, n=368) were invited to participate. Questionnaires were applied to parents (separately) and children (answered by both parents). Items included the size and frequency of foods to construct an index (ranked from 0 to 9). We used cluster analysis to set meal groups: light beverages (LB); fruits and vegetables (FV); pizza, candies, cakes, fried potatoes (PP); soda, pork and cow meat (PC); milk, bread, beans, tortilla, sugar loaf (BB). Canonical correlation was used. Redundancies of children preferences and their parents varied between 10.7 and 25.6%. We found differential infl uences from social status and gender upon children meal preferences. Preventive programs have to take into account reinforcement in maternal habits to infl uence on healthy food children preferences. Focus on fathers has to be in a different direction: to diminish the effect on fatty and sweet food.
T4:P4-036 DISTRIBUTION OF BODY MASS CATEGORIES AMONG SMOKERS, EX-SMOKERS AND NEVER SMOKERS IN POPULATION OF EASTERN POLAND
Mardarowicz Grażyna, Łopatyński Jerzy, Matej Agata Family Medicine Department, Medical University in Lublin, Poland Aim: of the study was to examine the body mass category and prevalence of impaired glucose tolerance (IGT) and diabetes mellitus type 2 (DM2) in never smokers, current smokers and former cigarette smokers in representative population sample. Methods: Questionnaire concerning smoking habits was studied in 603 smokers, 541 ex-smokers and 828 nonsmokers in the urban population and in 423, 310 and 1076 subjects in rural population, respectively. The body weight, height, body mass index (BMI), waist and hip circumference and waist to hip ratio (WHR) were measured and oral glucose tolerance test was performed. DM2 and IGT were diagnosed according to WHO criteria. Results: 48,1% of the examined in countryside (77,9% F, 23% M) and 36,8% in the town (48,8% F, 21,1% M) have never smoked cigarettes. 38,7% of the examined in countryside (18,8% M, 55,7% F) and 42,9% in the town (34,8% F, 53,5% M) are current smokers. 56,3% of current smokers in rural and 46,6% in urban population were normal weight, 30,9% in rural and 32,2% in urban population were overweight and only 12,8% in rural and 21,2% in urban population were obese. Half of the ex-smokers were overweight. The prevalence of DM2 among normal-weight current smokers was 5,6% and among normal-weight never-smokers -9,7%. DM2 was recognised in obese current smokers in 18,7% and in obese never-smokers in 28,4%. The mean WHR was signifi cantly higher among obese diabetic smoking women than in obese diabetic non-smoking women.
Conclusions:
The prevalence of DM2 is lower among current smokers regardless of different BMI categories.
T4:P4-037 SERUM LEPTIN CONCENTRATION IN THE OBESE WITH METABOLIC SYNDROME AND IN ISOLATED OBESITY
Mardarowicz Grażyna, Łopatyński Jerzy, Szcześniak Grzegorz Family Medicine Department, Medical University of Lublin, Poland
Aims: The aim of this study was to compare the hyperleptinemia in the obese with metabolic syndrome (MS) and without concomitant metabolic disturbances. Methods: We studied 22 men in the mean age 52,5 ± 8,8 years and the mean body mass index (BMI) 32,5 ± 2,4 kg/m 2 , with diabetes mellitus type 2 or impaired glucose tolerance and hypertension, hypertriglyceridemia and hypo-HDL-cholesterolemia and 22 men in the mean age 53,0 ± 9,4 years and the mean BMI 33,2 ± 2,5 kg/m 2 with isolated obesity and 34 women with metabolic syndrome and 34 women with isolated obesity in comparable mean age and mean value of BMI. We performed blood pressure measurements, anthropometric measurements (height, weight, waist and hip circumferences, four skin-fold thickness) and laboratory tests (oral glucose tolerance test, blood lipids, serum fasting insulin and serum insulin -120 minutes after 75 g glucose load and serum fasting leptin). We assessed BMI, waist to hip ratio and total fat amount using the Siri method. Results: Total fat amount among men with MS was 36,7 ± 4,4% and among men with isolated obesity was 32,8 ± 4,5% and among women with MS was 45,2 ± 2,9% and among women with isolated obesity was 43,2 ± 2,4%. The mean serum leptin in the studied subgroups was: 6,1 ± 3,5, 7,1 ± 4,5 and 26,7 ± 18,8, 26,3 ± 17,5 ng/ml, respectively. The mean serum fasting insulin was 14,9 ± 9,2, 9,9 ± 6,2 and 9,7 ± 4,4, 7,8 ± 4,3 µU/ml and postprandial serum insulin: 150,3 ± 79,5, 34,5 ± 16,9 and 97,4 ± 58,3, 44,9 ± 34 µU/ml, respectively. Conclusions: We observed no signifi cant differences between serum leptin concentrations among the obese with and without MS. Aims: To evaluate the relationship between body composition and L-T4 requirements in patients with thryoid diseases. Methods: A total of 75 patients enrolled after total thyroidectomy, on TSH-suppressive doses of L-T4, were assigned to one of three groups: normal-weight (NW), overweight (OW) and obese (OB).
T4:P4-
Results:
The total daily dose of L-T4 was lower in NW (127.5±21.3 µg/ day) vs. OW (139.4±24.5) and OB (151.3±29.1). There was a signifi cant correlation between the L-T4 daily dose and body weight (p<0.0001, R = 0,611). The association was much stronger when the L-T4 dose was correlated with lean mass (LM) (p<0.0001, R = 0,667) than with fat mass (p = 0.023, R = 0.26), as assessed by DEXA. Measurement of regional tissue composition showed peripheral LM as the best correlate with the total daily dose of L-T4 (R=0.679, p<0.0001). The mean total daily dose of L-T4 was signifi cantly higher in male than in female, but there was no difference when the daily dose of L-T4 was corrected for body weight. A signifi cant negative correlation was observed between patients' age and the L-T4 daily dose corrected for body weight, while no relationship was observed after correction for LM. Conclusions: Individual L-T4 requirements in subjects receiving hormonal therapy for thyroid diseases are greatly dependent on the respective lean body mass. Age-as well as gender-related differences in L-T4 needs refl ect different proportions of lean mass over the total body weight. Aims: To investigate associations between fasting plasma glucose, body mass index (BMI), and components of body composition. Methods: 337 women, divided into the pre-menopause group (n=139) and post-menopause group (n=198) were studied. The sample was also sub-divided into normoponderal, pre-obese and obese groups. We evaluated the weight, height, BMI and, using a radiologic densitometry technique (QDR 4500 -Hologic, Inc.), total fat and lean body mass. Percentage of fat mass was also calculated. Fasting plasma glucose and plasma insulin were measured. Data underwent descriptive analysis, for determination of average and standard deviation, and comparative and regression analysis. Results: Fasting plasma insulin was signifi cantly higher in obese women (P<0,05), when compared with the other groups. A positive relation between total body fat mass and fasting plasma glucose, in post-menopause women, was also observed. Conclusions: Our results seem to sustain the importance of glucose and insulin monitoring within obese women, mainly in post-menopause condition. It also seems to emphasise the need to induce life style modifi cations, meaning adequate dietary options and regular physical activity, to obtain the desirable reduction of insulin resistance. Results: Triglycerides were higher in the CVC group. Abdominal and total body fat percentages were higher in CVR and CVC compared to the control group (p=0,000) Conclusions: Despite similar BMI, the DEXA method was able to identify higher proportions of total body and abdominal fat mass in CVR and CVC groups. Results seem to sustain DEXA as a valuable method for body composition evaluation in post-menopause women with associated cardiovascular risks. Aims: The preferred generic measure of health benefi t in economic models is health-related utility. Utility provides a single measure of health preference and has interval properties. A number of treatments are now available to treat obesity. The purpose of this study was to characterise the relationship between health utility and obesity as measured by body mass index (BMI). Methods: Data were extracted from the Health Outcomes Data Repository (HODaR), which includes medical histories (almost no exclusion criteria), biochemistry, health-related utility (EQ5D), risk factors (including height and weight) and demographic data on a large number of individuals. The data used here (n=18,223) were from hospital inpatients and outpatients. Univariate analysis was conducted for specifi c sub-groups and risk factors, as well as multivariate modelling. Results: The general pattern was non-linear (rotated J-shaped curve). Naturally, there was wide variability but defi nite underlying structure to the relationship. People had highest utility when BMI=20 kg.m . This rate of deterioration was consistent for a range of subgroup analyses: age, sex, employment status and by broad disease categories, the general association remaining the same, only the intercept varying. Conclusions: Health-related utility is a function of obesity. These data characterise this relationship for the fi rst time, and in a large group of subjects. The pattern of this association was consistent in all subgroups investigated, and suggests that much health benefi t can be achieved by reducing obesity in the general population.
T4:P4-040 BODY COMPOSITION AND INSULIN RESISTANCE IN A SAMPLE OF PORTUGUESE WOMEN IN THE PRÉ AND POST-MENOPAUSE CONDITION
T4:P4-041 ABDOMINAL ADIPOSE TISSUE IN POST-MENOPAUSE WOMEN WITH AND WITHOUT CARDIOVASCULAR RISK AND WITH CARDIOVASCULAR COMPLICATIONS
T4:P4-042 EVALUATION OF THE ASSOCIATION BETWEEN HEATH-RELATED UTILITY AND OBESITY IN HOSPITAL-TREATED SUBJECTS
T4:P4-043 ASSESMENT OF BONE TISSUE CONDITION IN WOMEN WITH OBESITY IN POSTMENOPAUSE PERIOD
Melnichenko Galina, Boutrova Svetlana, Chigarkova Olga, Ilyin Alexandr Russian Endocrinology Research Center, Moscow, Russia Aim: To assess a condition of bone tissue mineral density (BTMD), calcium-phosphorus metabolism and biochemical markers refl ecting the condition of bone metabolism, and estradiol level in women with obesity in the postmenopause period. Methods: Women with obesity in the postmenopause period, without coexisting endocrinological pathology (n = 31, BMI 27-40 kg/m 2 , age 45-65, menopause duration 5-10 years) participated in the study. BTMD of the lumbar part of spinal cord, proximal part of femur, compositional body structure by "total body" program (Prodigy luhar model), ionized calcium (Ca ++ ) and inorganic phosphate (P) in blood serum; Ca and P in morning urine (biochemical analizator), parathormone (PH) (Elecsyc), total alkaline phosphatase (TAP), osteocalcitonin (OK), B-crosslap (One-step Elisa) in serum; deoxypiridinolinum (DPID) in morning urine in relation with creatinine (immulite) and blood estradiol (Elecsys) were studied. Results: Total body: fat tissue 46 kg (4.3), lean tissue 47 kg (2.5), fat coeffi cient 49% (2.2). There was no osteoporosis at lumbar vertebrae L2-L4 analyzing BTMD, osteopenia was diagnosed in 25.8% (n=8). Femur osteoporosis: in femoral neck 3.2% (n=1), in Ward triangle area 9.7% (n=3); osteopenia in femoral neck 12.9% (n=4), in Ward triangle area 45.15% (n=14); in trochanteris 3.2% (n=1). Maximal BTMD loss is discovered in Ward triangle area. Ca-P, PH, TAP, OK, B-crosslap fi ndings were in normal ranges. DPID increase was discovered in 39% (n=12), estradiol increase in 30% (n=9) cases. There was no signifi cant correlation between estradiol and body mass, BMI, fat tissue, and fat coeffi cient analyzing received data. Negative correlation was marked between body mass and B-crosslap, the resorption marker (r = -0.35; p = 0.045). Conclusion: There were no discovered lumbar vertebrae osteoporosis, Ca-P metabolism malfunctions and bone synthesis markers in women with obesity in the postmenopause period. Aims: To assess the effects of orlistat 120 mg three times daily versus placebo on weight loss and plasma concentration of oxidized LDL (oxLDL) in obese hypercholesterolemic patients. Methods: A 24-week multicentre, double-blind, randomised, placebocontrolled trial. After a 2-week single-blind run-in period, 290 patients were submitted to the hypocaloric diet and randomly assigned to either orlistat 120 mg or placebo three times daily. Patients who completed the double-blind study were eligible for participation in a subsequent 24-week open-label extension phase. Results: During run-in, weight reduction was associated with a significant decrease in both oxLDL (1.37±1.09 to 1.21±0.68 mg/dL; P=0.015) and LDL-C (196±25 to 182±30 mg/dL; P<0.001). After randomisation, orlistat-treated patients achieved a more rapid and signifi cantly greater weight loss than placebo-treated patients (-6.8% versus -3.8%, respectively; P<0.001). Levels of oxLDL decreased in orlistat-treated patients (1.33±0.77 at week -2 to 1.04±0.53 mg/dL at week 24; P<0.001), whereas in placebo-treated patients there was no signifi cant decrease in the levels of oxLDL. Adjunction of orlistat during the extension phase in patients who initially received placebo induced a further decrease in weight, total cholesterol, LDL-C and oxLDL (further decrease to 1.01±0.55 mg/dL; P<0.01). The decrease in the levels of oxLDL was due to a decrease in the concentration of LDL-C. Conclusion: Weight loss, obtained by a hypocaloric diet and treatment with orlistat, is associated with a decrease in plasma levels of oxidized LDL.
T4:P4-044 WEIGHT LOSS IS ASSOCIATED WITH A DECREASE IN PLASMA LEVELS OF OXIDIZED LDL
T4:P4-045 NON-VIRAL/NON-ALCOHOLIC LIVER STEATOSIS IS ASSOCIATED WITH ABDOMINAL OBESITY, NOT WITH THE BODY MASS INDEX
Mihaela Dinca, Eugen Georgescu University of Medicine and Pharmacy, Craiova, Romania Aims: To evaluate the occurrence of Liver Steatosis (LS) within the framework of obesity, the correlation with its type and its biochemical peculiarity. Methods: A total of 386 patients were evaluated (Set A -198 women and Set B -199 men) by Body Mass Index (BMI), Waist to Hip Ratio (WHR), semiotic liver/spleen estimation, determination of aminotransferases, gamma-glutamil transpeptidase (gamma GT), lipid profi le, insulin level, glucose tolerance and liver scanning. Results: Set A -LS was found in 23.5% subjects (based on BMI), out of which 11.2% were within the framework of overweight (BMI: 25-29.9) and 12.3% within the framework of obesity (BMI over 30), and in 72.4% subjects, correlated with WHR (over 80). Set B -LS was present in 3.2% of the overweight cases, 4.8% in obesity cases (based on BMI) and 70.5% correlated with WHR (over 94). LS characteristics, associated with abdominal obesity, were: important hepatomegaly, moderate increase of aminotransferases, moderate increase of gamma GT, hyperinsulinemia, hypertriglyceridemia, glucose intolerance, bright liver-scanning aspect, with no signs of portal hypertension. Conclusions: LS is correlated with abdominal obesity and not with the BMI, not infl uenced by the sex. Biochemical syndrome, associated with LS, is extremely close to the metabolic syndrome. Aims: To determine the response of lift manufacturers to increasing obesity rates Methods: Data were collected from 100 lifts installed over a 30-year period. Weight allowance per person was plotted against the year of installation and then correlated to obesity rates in the UK. Results: Year of installation had a signifi cant effect on weight allowance per person (R 2 =0.601, P = 0.000). The increase in weight allowance per person was signifi cantly correlated to the increased prevalence of obesity in the UK (Males R 2 =0.948, P =0.000, Females R 2 0.883, P = 0.000) Conclusions: Lift manufacturers demonstrate their responsiveness to the increasing prevalence of obesity. Other manufacturing industry (airplanes, seat belts, etc.) shows similar social awareness. Such awareness seems greater than in health care institutions where recognition of the need for heavier weight equipment in terms of outpatient seating and theatre-operating tables is poor. Aims: To analyze the association of BMI and age with metabolic syndrome components, i.e. impaired glucose tolerance, increased levels of triglycerides and LDL-C, decreased HDL-C, and hypertension in overweight and obese subjects. Methods: Thirty-two patients (24 female and 8 male), with mean age 34.1±13.5 y, and mean BMI 39.7±8.0 kg/m 2 (ranged 26.8-56.5), enrolled into the weight-loss program, were determined with respect to baseline values of fasting and postload plasma glucose and insulin levels during OGTT, lipid profi le, and BP. Results: Elevated fasting and postload insulin levels were measured in 13 (40.6%), and 12 (37.5%) of subjects. HOMA-IR index above 3.8 mU/L was determined in 8 (25.0%) of patients, but only 2 patients were presented as impaired glucose tolerance (postload glucose level 7.8 -11.1 mmol/L). Hypertriglyceridemia, hypertension, increased total cholesterol, LDL-C, and VLDL-C were shown in 22 (68.8%), 19 (59.4%), 15 (46.9%), 12 (37.5%) and 21 (65.6%) of participants, respectively. Low HDL-C level had 11 (34.4%) of program subjects. BMI was positively correlated with both postload glycemia and HOMA-IR. Fasting plasma glucose and LDL-C level were also signifi cantly increased by the patient age. Conclusions: Obtained data confi rm that, in addition to yet insuffi cient determined genetic factors, insulin resistance markers depend on the extent of excessive body weight, in comparison with the epidemiologic data obtained in the population of Croatia. Aims: Obesity is becoming an increasingly important health issue. Abdominal obesity is 1 of 5 criteria of the metabolic syndrome (MS) as defi ned by the NCEP (ATP III). We examined the relationship between body weight and the clustering of cardiovascular (CV) risk factors in a representative rural population of two villages in Southern Greece. Methods: This cross-sectional study included 115 people, 41M and 74W (age 58±17y, BMI 28.7±5.6kg/m 2 ). Anthropometrical data, metabolic and CV risk factors and dietary intake (7 days dietary recall) have been evaluated. Results: In all, 37.4% of the population were obese and 38.2% were overweight; 66.1% had abdominal obesity, 61% had hypertriglyceridaemia, 7.8% had low HDL-cholesterol, 57.4% had high blood pressure and 11.3% had high fasting glucose. Overall, 27.0% of this population (36.6% M and 21.6% W) had MS (≥ 3 ATP III criteria). The MS was present in 14.2% of normal weight, 18.1% of overweight and 44.1% of obese people. Patients with MS were older and heavier, but without different caloric and fat intakes than people without MS. Conclusions: Our results show that clustering of metabolic abnormalities is common in a representative rural population in Southern Greece. Considerable heterogeneity was present in components of the MS. The unexpectedly high prevalence of overweight and obesity, and especially abdominal obesity, suggests that the problem is widespread and may have important implications for health care and CV prevention.
T4:P4-046 ELEVATING NEEDS -ENVIRONMENTAL ADAPTATIONS TO THE INCREASED PREVALENCE OF OBESITY
T4:P4-047 THE INFLUENCE OF BODY MASS INDEX AND AGE ON THE APPEARANCE OF METABOLIC SYNDROME COMPONENTS
T4:P4-048 PREVALENCE OF OBESITY AND METABOLIC SYNDROME IN A RURAL GREEK POPULATION
T4:P4-049 THE EFFECTS OF ROSIGLITAZONE ON LIVER FUNCTION AND BLOOD GLUCOSE LEVEL IN PATIENTS WITH TYPE II DIABETES AND FATTY LIVER
Petrogiannopoulos Costas, Papamichael Kostas, Flevaris Christos, Svoukas George, Vassilopoulos George, Kanakis Kostas, Zaharof Antonis Hellenic Red Cross Hospital, Athens, Greece Aims: It is well known that rosiglitazone is used for treatment of type II diabetes.Type II diabetes is often associated with fatty liver.The aim of our study was to evaluate the effects of rosiglitazone in blood glucose levels and liver function in patients with type II diabetes and fatty liver. Methods: We studied 34 patients with type II diabetes and fatty liver that was proved histologically. All the patients were overweight (BMI>25Kg/m 2 ) and their blood glucose levels varied from 180 to 240.They received rosiglitazone 4mg twice daily for six months. Every month, biochemical tests for measuring blood glucose and liver enzymes levels were made. Results: After six months therapy with rosiglitazone, 25 patients (71,4%) accepted to have a new liver biopsy and 10 of them (40%) had histological improvement, concerning the reduction of hepatocellular ballooning and perisinusoidal fi brosis. All the patients had reduced the liver enzymes (AST 75→ 39, ALT 88→ 43) and the blood glucose levels by 30%. Conclusions: These data provided evidence for the protective role of rosiglitazone, reducing both blood glucose and liver enzyme levels.
T4:P4-050 THE FAT DISTRIBUTION AND GALLBLADDER MOTOR FUNCTION IN OBESE GALLSTONE WOMEN
Polaruch Natalija, Dvoryashina Irina Northern State Medical University, Arkhangelsk, Russia Aims: Few childhood obesity-treatment programmes use rigorous clinical methods of evaluation to assess the outcomes of the intervention. Therefore, this study reports on the acute clinical outcomes of a residential weight-loss camp programme. Methods: 30 children attending the Carnegie weight-loss camp (mean age=14.6 ± 1.91) and 30 overweight children (mean age 13.4±1.32) were compared using a range of clinical health measures. All children were assessed for body mass, stature, body composition using the 4-component model, total abdominal adipose tissue (TAAT) by MRI, blood pressure, aerobic fi tness and a range of metabolic variables before and after the six-week programme. Results: Signifi cant group by time interactions were seen in most variables. Particularly strong interactions were seen in body mass (F=237.8;P=0.00), fat mass (F=57.7; P=0.00), TAAT (F=50.7; P=0.00), LDL (F=12.3; P=0.00), leptin (F=18.0; F=0.00) systolic blood pressure (F=8.3; P=0.00) and aerobic fi tness (F=20.5; P=0.000). Changes pre to post for the campers showed positive improvements in respect to the above measures (↓8%, ↓11%, ↓12%, ↓22%, ↓45%, ↓6%, ↑16%), while the comparison group generally moved in the opposite direction. Conclusions: These signifi cant positive acute improvements in a range of clinical health measures provide strong objective evidence that substantiates the effi cacy of this treatment model. Follow-up studies are currently underway to evaluate the sustainability of these improvements, although the acute outcomes are encouraging. To analyze BP and cardiorenal (CR) parameters upon adiposity patterns (AP) and their changes to antihypertensive therapy. Methods: A total of 39 normotensive/49 hypertensive obese (NTOB/ HTOB) were, respectively, distributed accordingly to waist/hip in visceral (V-17/37)/ nonvisceral (NV-18/12) groups. Biochemistry, ABPM, echocardiography and microalbuminuria were performed in NTOB and after a 4-week antihypertensives washout in HTOB, followed by 24 weeks of stepwise regime: cilazapril 2.5-5.0mg; cilazapril 5.0 plus HCTZ12.5mg; anlodipine 5.0-10mg ( were found in V/NTOB. In NTOB W/H and waist predicted echo structural/ diastolic parameters, as so as HR, by multiple regression (MR). Insulin predicted ST/HR with W/H exclusion. V-HTOB had lower SBP dippering (%) (9.5±4.0 vs 12.9 ± 5.3 * ) and a trend to higher micro(36[6,1-96] vs 15 [7, 6] ) and left ventricular mass/height 2,7 (54.7±14 vs 50.2±5.6). n-SBP/n-DBP predicted echo structure and micro in HT (MR). After 24-w, weight loss was less than 2% in HTOB groups, but ABPM detected 91.8% effi cacy. V/NV needed similar drug amounts and had similar d-BP decay. n-SBP decay was higher in V(19.3±14.3 vs 10.4 ±11.5 Conclusions: V obesity was associated with CR damage and worse n-BP dippering; AP did not infl uence drugs needs, but n-BP fall; BP control provided micro normatization in V/NV OBHT; echo changes were smaller, probably due to poor weight loss. Aims: The objective of this study was to compare fat-free mass in the arms, legs and trunk, assessed by segmental multi-frequency bioimpedance analysis (SMFBIA) and dual-energy x-ray absorptiometry (DXA). Methods: A sample of participants in the Finnish Health 2000 Survey was invited to DXA examination. A total of 97 men and women aged 46 to 70 years, body mass index 19.4 to 43.1, were examined. In the baseline fi eld survey, the SMFBIA measurement had been conducted by InBody 3.0 (Biospace, South Korea). Segmental assessments of fat-free mass were calculated from impedance values of SMFBIA. Total body scan was carried out using DXA (Lunar DPX-IQ, USA).
T4:P4-051 INFLUENCES OF ADIPOSITY PATTERNS ON BLOOD PRESSURE AND CARDIORENAL PARAMETERS AND THEIR RESPONSES TO ANTIHYPERTENSIVE THERAPY
T4:P4-053 SEGMENTAL ASSESSMENTS OF FAT-FREE MASS BY BIOIMPEDANCE IN RELATION TO DXA
The segmental values of fat-free mass were calculated from scan data by adding bone mineral content to the lean tissue mass for all body segments. Results: Pearson correlation coeffi cients and mean differences (kg, in brackets) between SMFBIA and DXA methods for fat-free mass in different body segments were for the right and left arms 0.90 (-0.21 kg) and 0.79 (-0.46 kg), respectively. For the right and left legs, the corresponding fi gures were 0.93 (0.58 kg) and 0.95 (0.57 kg), respectively, and for the trunk 0.96 (0.88 kg).
Conclusions:
The results indicate that the SMFBIA is an accurate method for segmental assessment of fat-free mass. As being a simple, fast and inexpensive method, it could be particularly useful in extensive epidemiological studies. Aim: We aimed to investigate the changes of liver function tests and its correlations with insulin resistance, metabolic parameters and body fat distribution in obese women. Methods: Three hundred and two obese and sex -age-matched 52 nonobese subjects were included. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transpeptidase (GGT), fasting blood glucose (FBG), fasting insulin (I), total cholesterol (T-C),triglyceride (TG) and HDL -cholesterol (HDL -C) were determined. The thickness of visceral fat (VF) and subcutaneous fat (SCF) were measured by ultrasonography (USG). Insulin resistance (IR) was calculated by HOMA -IR formula. USG was used for determining steatohepatitis.
T4:P4-054 METABOLIC SYNDROME AS A RISK FACTOR FOR BREAST CANCER
Results: The frequency of steatohepatitis was found in 80.7% of obese, in 7% of nonobese subjects. GGT was higher in obese than nonobese subjects ( p<0.001), while ALT and AST were similar in both groups. Signifi cant correlations were found between liver function tests and FBG, BMI, HOMA -IR and waist circumference (WC). There was a positive correlation between ALT and I (r=0, 121) and VF (r=0, 204) . GGT was also correlated with .
Conclusions: This study indicates that IR is an important cause for developing steatohepatitis and the changes of liver function tests in obese subjects. Both total body fat and visceral fat contribute to these abnormalities. Aims: Vascular endothelial dysfunction (VED) plays a pivotal role in the pathogenesis of atherosclerosis and is associated with insulin resistance and visceral obesity. We examined VED in uncomplicated premenopausal obese women using analysis of endothelium-dependent vasodilation by radial artery pulse wave obtained through applanation tonometry, and whether VED could change signifi cantly after weight reduction. Methods: The subjects were included of forty-two uncomplicated premenopausal obese women (BMI>=25). Anthropometric measurements were performed, and regional distribution of adipose tissue and metabolic variables was measured. Endothelial function was measured through endothelium-mediated vasodilatation, contributed partially by nitric oxide (NO) release from 2-adrenergic stimulation. After 12 weeks of weight-reduction program was conducted in obese women, all the above measurements were repeated so that we could fi nd out the changes of VED and other obesity-related factors. 
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Conclusion:
These results are in accordance with the literature and stress the need for implementation of nutrition interventions to control OW. They also show that OW and its consequences in adulthood is an important issue in public health not only in developed societies, but also among low-income urban groups from developing countries. As social costs, the early incapacity to work associated with the increase in health service necessities will represent in the near future a challenge for developing societies.
A wise health strategy would be to prevent obesity and its consequences, instead of being overloaded by curative health services and welfare bills. Obesity is a disease that is characterized by excessive body fat accumulation to an extent that can lead to health disturbances and several complications. In obese patients, it has been recognized that they sometimes have a prolonged QT interval, which can lead to ventricular tachyarrhytmias, syncope or sudden death. The aim of this study was to evaluate the existence of prolonged QT interval after obesity treatment. A group of 60 obese patients was examined: 30 of them were treated with very low-calorie diet (VLCD, 300 kcal/day, one month) and 30 of them were treated with low-calorie diet and orlistat (600-kcal defi cit with < 30% of energy from fat, six months). In all of them, a 12-channel ECG was made. On every ECG, the QT interval was measured in 3 following hearth beats and the QTc was calculated by using Bazett's formula. Prolonged QT interval was present in 41.66% in the whole examined obese group. Signifi cant weight reduction was achieved in the group treated with VLCD and with orlistat (12.20% vs. 13,73%). In the group treated with VLCD, after the treatment, prolonged QTc was found in 43,33% and in the orlistat group in only 6,66% patients. In 8 (26,6%) patients treated with VLCD, we registered the prolonged QTc as for the fi rst time after the VLCD, and in 5 (16,6%) the prolonged QTc persisted from the start. These results show that it is important to choose correctly the patients for rapid weight loss such as VLCD. Aim: The aim of this study was evaluation of the effect of obesity on bone mineral density, bone turnover markers, and androgenic markers in the patients with PCOS. Methods: The diagnosis of PCOS was made on the basis of elevated androgen levels, increased LH/FSH levels, and visualizations of polycystic ovaries on pelvic USG. Patients with PCOS (n=26; mean age: 24,05±5,3 years) were compared to healthy control subjects (n=35; mean age 25,43±5.01 years). Then PCOS patients were divided into two groups, obese (group O; n=15; BMI 30 kg/m 2 ) and non-obese (group N; n=11; BMI<25 kg/m 2 ). Results: BMD measurements in the regions of L3 (-0,38±1,29 and 0,25±0,65; p=0.02), L4 (-0,67±1,28 and -0,03±0,66; p=0,019), total lumbar vertebra (-0,32±1,19 and 0,17±0,62; p=0,05) and T-scores were signifi cantly decreased in patients with PCOS compared to control subjects. In the group N, BMD measurements in the regions of L2 (-0,67±0,86 and 0,17±0,61; p=0,004), L3 (-0,99±0,79 and 0,26±0,15; p<0,0001), Total lumbar (-1,27±0,78 and 0,01±0,22; p<0,0001), femoral neck (-0,81±0,42 and -0,21±0,49; p=0,002) , and Wards (-0,88±0,81 and 0,23±0,94; p<0,0001) T-scores were found to be signifi cantly decreased Aims: To determine whether obesity is an independent risk factor for the development of coronary artery disease (CAD) in overweight and obese patients. Methods: In a population of 1266 patients (BMI>25 kg/m², range 25-70, mean 36; age>35 y), differences in cardiac risk factors and anthropometric parameters between patients with CAD (n=50) and a healthy control population without CAD (n=163), selected by a phone questionnaire, from the same obese population, were recorded. In addition, a group of patients suspected to have cardiac ischemia (n=137) and a healthy control population without signs of coronary ischemia (n=142) were compared. Analysis was done by logistic regression. Results: Both fi brinogen (p<0.007) and type 2 diabetes (p<0.017) were independent risk factors for the development of CAD, while patients with high levels of subcutaneous abdominal tissue (SAT; CT-scan L4-L5) had a reduced risk for CAD (p<0.032). In the group suspected to have ischemic disease, fi brinogen was a positive predictor (p<0.006), and SAT was a negative predictor for ischemic events (p<0.017). A positive trend for age, smoking and hypertension was also observed. Given the limited sample size, no defi nite conclusion could be made for overweight or obesity. Conclusions: Body fat distribution and fi brinogen seem to be predictive in the development of CAD in overweight and obese patients. Aim: In the last few decades, a large body of evidence witnessed for the changes in the ethiopathogenesis of atrial fi brillation (AF), since at present hypertension represents its fi rst cause. The aim of this study was to evaluate the infl uence of left ventricular mass (LVM) in obese subjects and the BP variability, on the incidence of AF in relation to insulinemic metabolism. Methods: We studied 35 hypertensive obese subjects (BMI= 34.7; 54.5 yrs) age and sex matched with 38 lean subjects (BMI= 24.2). All subjects underwent ABPM, 24-h ambulatory EKG recordings, echocardiography and OGTT, for determination of areas under glucose (AUGC) and insulin (AUIC) curves. Insulin resistance was evaluated indirectly (HOMA IR ). All hospitalizations related to cardiac problems were recorded in a specifi c database. Results: Our data, besides showing in obese subjects higher values of LVM related to insulin resistance (p< 0.001), pointed out that notwithstanding similar BP values in two groups AF recurred more commonly in obese subjects (p< 0.001). Multivariate regression analysis showed that the main determinants of AF recurrence were LVM, hyperinsulinism and insulin resistance (p< 0.0001), while regarding BP values we found an increased risk in subjects with higher BP variability and morning surge > 25 mmHg. Conclusions: Our data suggest a prime role of BP variability, circadian changes of BP values and hyperinsulinism related to LVH as the determinant of AF recurrence in obese subjects. Background: Dietary restraint has been widely linked with adverse outcomes, ranging from low self-esteem to binge eating. Worry about adverse effects makes parents and health professionals reluctant to recommend dietary restriction to children and adolescents who are becoming overweight, even though their best hope for the future may be to learn to manage their weight before they gain too much. However, recent fi ndings have suggested that some of the factors associated with dieting might be due not to restraint per-se, but to the body dissatisfaction with usually precedes and motivates it. Methods: Prospective data from a survey of 1177 adolescent girls in the North of England were used to examine whether emotional eating, binge eating, abnormal attitudes to eating and weight, low self-esteem, and depression are better understood as consequences of dietary restraint or body dissatisfaction. Measures were taken on two occasions, one year apart. Results: In analyses that included both restraint and body dissatisfaction as independent predictors, restraint was only associated with more negative attitudes to eating, while body dissatisfaction was signifi cantly associated with bulimic symptoms, emotional eating, low self-esteem and depression. In addition, restraint -independent of body dissatisfaction-was linked with better dietary choices and more physical activity, while body dissatisfaction -independent of dieting -was linked with poorer health behaviours. Discussion: These results highlight the need for research to fi nd out how to promote effective weight control while minimising damaging weight concern.
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